The emergence of a new industry is not due solely to the resource endowments and
competences of new firms, but is also tied to the creation of an organisational field that …

This volume analyzes the dynamics and interactive processes among the players
(individuals, institutions, and organizations/firms) that have constituted and legitimized the …

In commercial applications of biotechnology, there is no international convergence. On
many critical dimensions, the United States is pulling ahead vis-à-vis most other developed …

Executive Summary This report Health Biotechnology: Emerging Business Models and
Institutional Drivers addresses the future of firms and industry. In particular, the report …

This paper is a case study of the transformation in research methods which occurred in a
large US pharmaceutical firm as a result of the biotech revolution. This transformation is …

This work is a sociological history of the origins of the biotechnology industry in San Diego,
California. It focuses on the professional biographies of scientists and executives at …

Management of successful incumbent firms experience difficulty in recognizing the need for,
and effecting change in the firm's technological identity after an externally generated shift in …

Most research on the emergence of high-tech clusters samples on successful cases, and
works backwards to trace a narrative, often highlighting the role of specific individuals or …

We argue that the decision of inventors to build upon a pioneering technology is a function
not just of technical merit but also of social forces. The identification of technological …

Over the past three decades, the biotechnology industry has emerged as a vital and
dynamic source of new technologies for the pharmaceutical and agricultural chemical …